Real-world safety check for entresto in japanese hypertension patients
NCT ID NCT05976230
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows about 1,100 Japanese adults with high blood pressure who are prescribed Entresto tablets. Researchers track side effects like low blood pressure, high potassium, and kidney issues over 52 weeks. The goal is to see how safe and effective Entresto is in everyday medical practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Entresto (sacubitril/valsartan)
What this could lead to
If successful, this study could confirm that Entresto is a safe and effective long-term option for managing high blood pressure in Japanese patients.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by other factors. Risks include low blood pressure, high potassium, and kidney problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Anjo, Aichi-ken, 444-1154, Japan
-
Novartis Investigative Site
Ichinomiya, Aichi-ken, 494-0001, Japan
-
Novartis Investigative Site
Kasugai, Aichi-ken, 487-0024, Japan
-
Novartis Investigative Site
Nagoya, Aichi-ken, 460-0004, Japan
-
Novartis Investigative Site
Okazaki, Aichi-ken, 444-0856, Japan
-
Novartis Investigative Site
Ōbu, Aichi-ken, 474-0044, Japan
-
Novartis Investigative Site
Toyohashi, Aichi-ken, 440-0836, Japan
-
Novartis Investigative Site
Yatomi, Aichi-ken, 498-0048, Japan
-
Novartis Investigative Site
Inzai, Chiba, 270-1334, Japan
-
Novartis Investigative Site
Matsudo, Chiba, 270-0034, Japan
-
Novartis Investigative Site
Sakura, Chiba, 285-8765, Japan
-
Novartis Investigative Site
Yotsukaidō, Chiba, 284-0027, Japan
-
Novartis Investigative Site
Matsuyama, Ehime, 790-0051, Japan
-
Novartis Investigative Site
Matsuyama, Ehime, 790-0932, Japan
-
Novartis Investigative Site
Saijō, Ehime, 799-1371, Japan
-
Novartis Investigative Site
Fukuoka, Fukuoka, 815-0033, Japan
-
Novartis Investigative Site
Fukuoka, Fukuoka, 815-0041, Japan
-
Novartis Investigative Site
Kasuga, Fukuoka, 816-0807, Japan
-
Novartis Investigative Site
Kasuga, Fukuoka, 816-0833, Japan
-
Novartis Investigative Site
Kasuya Gun, Fukuoka, 811-2202, Japan
-
Novartis Investigative Site
Kitakyushu, Fukuoka, 804-0081, Japan
-
Novartis Investigative Site
Kitakyushu, Fukuoka, 805-0019, Japan
-
Novartis Investigative Site
Kurume, Fukuoka, 830-0011, Japan
-
Novartis Investigative Site
Nakagawa, Fukuoka, 811-1244, Japan
-
Novartis Investigative Site
Omuta, Fukuoka, 837-0916, Japan
-
Novartis Investigative Site
Yame, Fukuoka, 834-0004, Japan
-
Novartis Investigative Site
Hiroshima, Hiroshima, 731-0102, Japan
-
Novartis Investigative Site
Hiroshima, Hiroshima, 731-0154, Japan
-
Novartis Investigative Site
Hiroshima, Hiroshima, 731-0221, Japan
-
Novartis Investigative Site
Takehara, Hiroshima, 725-0026, Japan
-
Novartis Investigative Site
Sapporo, Hokkaido, 001-0017, Japan
-
Novartis Investigative Site
Sapporo, Hokkaido, 060-0031, Japan
-
Novartis Investigative Site
Sapporo, Hokkaido, 064-0802, Japan
-
Novartis Investigative Site
Sapporo, Hokkaido, 064-0809, Japan
-
Novartis Investigative Site
Akashi, Hyōgo, 673-0023, Japan
-
Novartis Investigative Site
Amagasaki, Hyōgo, 660-0861, Japan
-
Novartis Investigative Site
Kasai, Hyōgo, 679-0103, Japan
-
Novartis Investigative Site
Kobe, Hyōgo, 650-0047, Japan
-
Novartis Investigative Site
Kobe, Hyōgo, 651-1302, Japan
-
Novartis Investigative Site
Kobe, Hyōgo, 651-1505, Japan
-
Novartis Investigative Site
Kobe, Hyōgo, 651-2135, Japan
-
Novartis Investigative Site
Kobe, Hyōgo, 654-0121, Japan
-
Novartis Investigative Site
Nishinomiya, Hyōgo, 663-8107, Japan
-
Novartis Investigative Site
Bandō, Ibaraki, 306-0631, Japan
-
Novartis Investigative Site
Chikusei, Ibaraki, 309-1195, Japan
-
Novartis Investigative Site
Koga, Ibaraki, 306-0232, Japan
-
Novartis Investigative Site
Moriya, Ibaraki, 302-0118, Japan
-
Novartis Investigative Site
Ryūgasaki, Ibaraki, 301-0005, Japan
-
Novartis Investigative Site
Kanazawa, Ishikawa-ken, 920-0007, Japan
-
Novartis Investigative Site
Kagoshima, Kagoshima-ken, 892-0862, Japan
-
Novartis Investigative Site
Aiko-gun, Kanagawa, 243-0301, Japan
-
Novartis Investigative Site
Fujisawa, Kanagawa, 252-0804, Japan
-
Novartis Investigative Site
Yokohama, Kanagawa, 225-0013, Japan
-
Novartis Investigative Site
Yokohama, Kanagawa, 2260025, Japan
-
Novartis Investigative Site
Yokohama, Kanagawa, 2270046, Japan
-
Novartis Investigative Site
Yokohama, Kanagawa, 232-0052, Japan
-
Novartis Investigative Site
Yokohama, Kanagawa, 235-0045, Japan
-
Novartis Investigative Site
Yokohama, Kanagawa, 241-0821, Japan
-
Novartis Investigative Site
Yokosuka, Kanagawa, 238-0007, Japan
-
Novartis Investigative Site
Kumamoto, Kumamoto, 862-0924, Japan
-
Novartis Investigative Site
Yamaga, Kumamoto, 861-0382, Japan
-
Novartis Investigative Site
Iki, Nagasaki, 811-5135, Japan
-
Novartis Investigative Site
Nagasaki, Nagasaki, 852-8055, Japan
-
Novartis Investigative Site
Nagasaki, Nagasaki, 852-8511, Japan
-
Novartis Investigative Site
Nakatsu, Oita Prefecture, 871-0152, Japan
-
Novartis Investigative Site
Ōita, Oita Prefecture, 870-0837, Japan
-
Novartis Investigative Site
Kurashiki, Okayama-ken, 710-1101, Japan
-
Novartis Investigative Site
Kurashiki, Okayama-ken, 713-8121, Japan
-
Novartis Investigative Site
Hirakata, Osaka, 573-0058, Japan
-
Novartis Investigative Site
Ikeda, Osaka, 563-0047, Japan
-
Novartis Investigative Site
Minoo, Osaka, 562-0046, Japan
-
Novartis Investigative Site
Moriguchi, Osaka, 570-0012, Japan
-
Novartis Investigative Site
Moriguchi, Osaka, 570-8507, Japan
-
Novartis Investigative Site
Osaka, Osaka, 533-0013, Japan
-
Novartis Investigative Site
Osaka, Osaka, 534-0024, Japan
-
Novartis Investigative Site
Suita, Osaka, 565-0862, Japan
-
Novartis Investigative Site
Suita, Osaka, 565-0874, Japan
-
Novartis Investigative Site
Takatsuki, Osaka, 569-1121, Japan
-
Novartis Investigative Site
Toyonaka, Osaka, 561-0881, Japan
-
Novartis Investigative Site
Kashima, Saga-ken, 849-1311, Japan
-
Novartis Investigative Site
Kishima-gun, Saga-ken, 849-1203, Japan
-
Novartis Investigative Site
Tosu, Saga-ken, 841-0061, Japan
-
Novartis Investigative Site
Ureshino, Saga-ken, 843-0302, Japan
-
Novartis Investigative Site
Asaka, Saitama, 3510021, Japan
-
Novartis Investigative Site
Fujimino, Saitama, 356-0011, Japan
-
Novartis Investigative Site
Gyōda, Saitama, 361-0056, Japan
-
Novartis Investigative Site
Kawaguchi, Saitama, 333-0847, Japan
-
Novartis Investigative Site
Niiza, Saitama, 352-0023, Japan
-
Novartis Investigative Site
Saitama, Saitama, 339-0033, Japan
-
Novartis Investigative Site
Satte, Saitama, 340-0115, Japan
-
Novartis Investigative Site
Sayama, Saitama, 350-1305, Japan
-
Novartis Investigative Site
Tokorozawa, Saitama, 359-1106, Japan
-
Novartis Investigative Site
Tokorozawa, Saitama, 359-1141, Japan
-
Novartis Investigative Site
Akishima, Tokyo, 196-0015, Japan
-
Novartis Investigative Site
Edogawa-ku, Tokyo, 134-0081, Japan
-
Novartis Investigative Site
Hachiōji, Tokyo, 192-0918, Japan
-
Novartis Investigative Site
Katsushika-ku, Tokyo, 125-0042, Japan
-
Novartis Investigative Site
Kokubunji, Tokyo, 185-0011, Japan
-
Novartis Investigative Site
Koto-ku, Tokyo, 135-0003, Japan
-
Novartis Investigative Site
Machida, Tokyo, 194-0021, Japan
-
Novartis Investigative Site
Machida, Tokyo, 1940013, Japan
-
Novartis Investigative Site
Machida, Tokyo, 195-0074, Japan
-
Novartis Investigative Site
Mitaka, Tokyo, 181-0013, Japan
-
Novartis Investigative Site
Ōta-ku, Tokyo, 146-8531, Japan
-
Novartis Investigative Site
Setagaya-ku, Tokyo, 157-0066, Japan
-
Novartis Investigative Site
Shibuya City, Tokyo, 151-0053, Japan
-
Novartis Investigative Site
Toshima-ku, Tokyo, 171-0014, Japan
-
Novartis Investigative Site
Takaoka, Toyama, 939-1104, Japan
-
Novartis Investigative Site
Shimonoseki, Yamaguchi, 759-6301, Japan
-
Novartis Investigative Site
Yamaguchi, Yamaguchi, 754-0002, Japan
-
Novartis Investigative Site
Fukuoka, 810-0044, Japan
-
Novartis Investigative Site
Fukuoka, 810-0801, Japan
-
Novartis Investigative Site
Fukuoka, 812-0025, Japan
-
Novartis Investigative Site
Fukuoka, 812-0039, Japan
-
Novartis Investigative Site
Fukuoka, 814-0163, Japan
-
Novartis Investigative Site
Saitama, 3300074, Japan
-
Novartis Investigative Site
Saitama, 338-0837, Japan